The nearly 80-fold difference in oral bioavailability between orforglipron and oral semaglutide has several important consequences
Both are dosed subQ Same daily injection schedule No known stability conflict Synergistic: BPC-157 targets soft tissue (tendons, gut, ligaments), TB-500 (thymosin beta-4) addresses systemic healing and mobility Draw BPC-157 first, then TB-500 into the same syringe
Dose: 2 capsules twice day
Many people find that morning supplementation supports skin health and radiance
In particular, nano-formulation strategiesincluding polymeric nanoparticles, lipid-based nanocarriers, nanoemulsions, and micellar systemshave shown promise in improving solubility, stability, and pharmacokinetic behavior